VIM-1 carbapenemase-producing Escherichia coli isolated from retail seafood, Germany 2016

Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
Nicole RoschanskiUwe Roesler

Abstract

Carbapenems belong to the group of last resort antibiotics in human medicine. Therefore, the emergence of growing numbers of carbapenemase-producing bacteria in food-producing animals or the environment is worrying and an important concern for the public health sector. In the present study, a set of 45 Enterobacteriaceae isolated from German retail seafood (clams and shrimps), sampled in 2016, were investigated by real-time PCR for the presence of carbapenemase-producing bacteria. One Escherichia coli (ST10), isolated from a Venus clam (Ruditapes philippinarum) harvested in the Mediterranean Sea (Italy), contained the carbapenemase gene blaVIM-1 as part of the variable region of a class I integron. Whole-genome sequencing indicated that the integron was embedded in a Tn3-like transposon that also contained the fluoroquinolone resistance gene qnrS1. Additional resistance genes such as the extended-spectrum beta-lactamase blaSHV-12 and the AmpC gene blaACC-1 were also present in this isolate. Except blaACC-1, all resistance genes were located on an IncY plasmid. These results confirm previous observations that carbapenemase-producing bacteria have reached the food chain and are of increasing concern for public health.

References

Jul 17, 2004·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·B GuerraM C Mendoza
May 13, 2006·Molecular Microbiology·Thierry WirthMark Achtman
Apr 7, 2009·Diagnostic Microbiology and Infectious Disease·Scott A WeisenbergDavise H Larone
May 26, 2009·International Journal of Antimicrobial Agents·Jesús OteoUNKNOWN Spanish Network in Infectious Pathology Project (REIPI)
Jul 25, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M FalconeM Venditti
Dec 25, 2009·Emerging Infectious Diseases·Roméo Rocha SimõesPatrice Nordmann
Apr 10, 2010·The Journal of Antimicrobial Chemotherapy·Elizabeth B Hirsch, Vincent H Tam
Oct 18, 2011·Emerging Infectious Diseases·Patrice NordmannLaurent Poirel
Dec 24, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·I AibinuB Ghebremedhin
Dec 29, 2011·Antimicrobial Agents and Chemotherapy·Laurent PoirelPatrice Nordmann
Jan 13, 2012·Journal of Clinical Microbiology·Mette V LarsenOle Lund
Mar 29, 2012·The Journal of Antimicrobial Chemotherapy·Jennie FischerBeatriz Guerra
Jul 12, 2012·The Journal of Antimicrobial Chemotherapy·Ea ZankariMette Voldby Larsen
Oct 5, 2012·The Journal of Antimicrobial Chemotherapy·Jennie FischerBeatriz Guerra
Feb 28, 2014·Journal of Clinical Microbiology·Katrine Grimstrup JoensenFrank M Aarestrup
Apr 30, 2014·Antimicrobial Agents and Chemotherapy·Alessandra CarattoliHenrik Hasman
Jun 25, 2014·Emerging Infectious Diseases·Joseph E RubinChampika Fernando
Aug 8, 2014·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Katrin ZurfluhRoger Stephan
Dec 17, 2014·International Journal of Antimicrobial Agents·Lara Feital MontezziRenata Cristina Picão
Mar 25, 2015·Antimicrobial Agents and Chemotherapy·Sheila Adams-SapperLee W Riley
May 13, 2015·PloS One·Beverly J Morrison, Joseph E Rubin
Jan 8, 2016·Journal of Clinical Microbiology·Joseph D Lutgring, Brandi M Limbago
Aug 18, 2016·Emerging Infectious Diseases·Nicol JaneckoRichard J Reid-Smith

❮ Previous
Next ❯

Citations

Apr 25, 2018·Antimicrobial Agents and Chemotherapy·Michael S M BrouwerKees T Veldman
May 26, 2018·The Journal of Antimicrobial Chemotherapy·Arnaud BrietSophie A Granier
Feb 27, 2018·EFSA Journal·UNKNOWN European Food Safety Authority, UNKNOWN European Centre for Disease Prevention and Control
Mar 27, 2019·Antimicrobial Agents and Chemotherapy·Michael S M BrouwerKees T Veldman
Sep 2, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alainna J JamalAllison J McGeer
Oct 31, 2020·Scientific Reports·Philipp KohlerUNKNOWN Toronto Invasive Bacterial Diseases Network (TIBDN)
Jan 18, 2020·Microbiology Spectrum·Patrícia AntunesLuísa Peixe
Jun 29, 2021·EFSA Journal·UNKNOWN EFSA Panel on Biological Hazards (BIOHAZ)Luisa Peixe
Jul 14, 2018·Microbiology Spectrum·Laurent PoirelStefan Schwarz
Apr 6, 2021·Deutsches Ärzteblatt International·Robin KöckBirgit Walther
Sep 28, 2021·Canadian Journal of Microbiology·Dongyun JungJoseph E Rubin

❮ Previous
Next ❯

Datasets Mentioned

BETA
PDDP00000000
MG182343

Methods Mentioned

BETA
electrophoresis
phosphotransferase

Software Mentioned

BlastSearch
Basic Local Alignment Search Tool ( BLAST
MLST
Geneious
VirulenceFinder
CLC Genomics workbench
ResFinder
PlasmidFinder

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2022 Meta ULC. All rights reserved